Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of evolocumab versus high-intensity statin for early intensive LDL-C reduction in acute coronary syndrome
KCT0009668Phase 3Recruiting
- Sponsor
- The Korean Society of Cardiology
- Start
- Feb 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of evolocumab in acute coronary syndrome (ACS), sponsored by The Korean Society of Cardiology. Started Feb 2025; status: recruiting.
02
Drugs
evolocumab
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on KCT0009668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009668.